Company: DMAC
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001437749-25-009696
Chunk: 61

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 61
---
 granted during the year that are outstanding and unvested(c)      |     |   |   75,730 |   |
| Add: Change in fair value of equity awards granted in prior years that are outstanding and unvested(d) |     |   |  (36,824 | ) |
| Add: Change in fair value of equity awards granted in prior years that vested during the year(e)       |     |   |  (13,673 | ) |
| Add: Value of dividend equivalents accrued on equity awards during the year                            |     |   |        — |   |
| Compensation Actually Paid for 2022                                                                    |     |   |  507,196 |   |

| (a) | Represents the total of the amounts reported in the “Stock Awards” column in the Summary Compensation Table for the applicable year. |

| (b) | Represents the total of the amounts reported in the “Option Awards” column in the Summary Compensation Table for the applicable year. |

| (c) | Represents the year-end value of equity awards granted during the applicable year that are outstanding and unvested as of the end of such applicable year. |

| (d) | Represents the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any equity awards granted in prior years that are outstanding and unvested as of the end of such applicable year. |

| (e) | Represents the amount of change as of the vesting date (from the end of the prior fiscal year) in fair value of any equity awards granted in prior years that vested during the applicable year. |

Since we do not have a pension plan, all of the foregoing adjustments are equity award adjustments for each applicable year and include the addition (or subtraction, as applicable) of the following: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of such applicable year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any equity awards granted in prior years that are outstanding and unvested as of the end of such applicable year; (iii) for equity awards that are granted and vest in the same applicable year, the fair value as of the vesting date; (iv) for equity awards granted in prior years that vest in the applicable year, the amount equal to the